The S&P 500 Futures are consolidating after they closed higher on Tuesday.
Later today, the Automatic Data Processing (ADP) will post private jobs for November (+0.43 million jobs expected). The Federal Reserve will release its economic report, the Beige Book.
European indices are trying to rebound after a negative open. Pfizer/Biontech Covid-19 vaccine was approved for use in UK and will be available from next week. The German Federal Statistical Office has released October retail sales at +2.6% (vs +1.2% on month expected). The European Commission has posted October PPI at +0.4% (vs +0.2% on month expected) and jobless rate at 8.4%, as expected.
Asian indices closed unchanged. Official data showed that Australia's 3Q GDP fell 3.8% on year, while a 4.4% decline was expected.
WTI Crude Oil is consolidating. The American Petroleum Institute (API) reported that U.S. crude-oil inventories increased 4.15 million barrels in the week ending Nov. 27 (-2.36 million barrels expected). Later today, the International Energy Agency (EIA) will release official crude oil inventories data for the same week (-2.358M expected).
U.S indices closed up on Tuesday, lifted by Technology Hardware & Equipment (+2.65%), Insurance (+2.3%) and Media (+2.27%) sectors.
Approximately 91% of stocks in the S&P 500 Index were trading above their 200-day moving average and 78% were trading above their 20-day moving average. The VIX Index rose 0.2pt (+0.97%) to 20.77 at the close.On the U.S economic data front, Markit's US Manufacturing Purchasing Managers' Index remained at 56.7 on month in the November final reading (as expected), in line with the November preliminary reading. Finally, Construction Spending rose 1.3% on month in October (+0.8% expected), compared to a revised -0.5% in September.
Gold gains ground as the U.S dollar remains weak on U.S stimulus talks.
Gold rose 8.38 dollars (+0.46%) to 1823.62 dollars.
The dollar index gained 0.1pt to 91.413, slightly rebounding after having hit its lowest level since late April 2018.
U.S. Equity Snapshot
Pfizer (PFE) and BioNTech (BNTX), the pharma, "announced that the Medicines & Healthcare Products Regulatory Agency (MHRA) in the U.K. has granted a temporary authorization for emergency use for their COVID-19 mRNA vaccine (BNT162b2), against COVID-19."
Source: TradingView, GAIN Capital
Salesforce.com (CRM), a developer of business software, revealed that it will acquire Slack Technologies (WORK), the collaboration hub, for 27.7 billion dollars. Separately, the company reported third quarter adjusted EPS of 1.74 dollar, up from 0.75 dollar a year ago on revenue of 5.4 billion dollars, up from 4.5 billion dollars a year earlier.Hewlett Packard Enterprise (HPE), a supplier of information technology products and services, raised its full year 2021 adjusted EPS guidance to 1.60-1.78 dollar vs 1.56-1.76 dollar previously.
NetApp (NTAP), a leading provider of data management and storage solutions, announced second quarter adjusted EPS of 1.05 dollar, beating estimates, down from 1.09 dollar a year ago on net sales flat at 1.4 billion dollars, better than expected.
Disclaimer: StoneX Financial Ltd. (trading as "Forex.com") is an execution-only service provider. This material, whether or not it states any opinions, is for general information purposes only and it does not take into account your personal circumstances or objectives. This material has been prepared using the thoughts and opinions of the author and these may change. However, Forex.com does not plan to provide further updates to any material once published and it is not under any obligation to keep this material up to date. This material is short term in nature and may only relate to facts and circumstances existing at a specific time or day. Nothing in this material is (or should be considered to be) financial, investment, legal, tax or other advice and no reliance should be placed on it.
No opinion given in this material constitutes a recommendation by Forex.com or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although Forex.com is not specifically prevented from dealing before providing this material, Forex.com does not seek to take advantage of the material prior to its dissemination. This material is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.
For further details see our full non-independent research disclaimer and quarterly summary.